This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
JHEOR
  • Menu
  • Articles
    • Author Correction
    • Autoimmune Diseases
    • Brief Report
    • Cardiovascular Conditions
    • Commentary
    • Correspondence
    • Dermatological Diseases
    • Endocrinology
    • Gastrointestinal Conditions
    • General Indications
    • Genetic Disorders
    • Hematology
    • Infectious Diseases
    • Methodology and Healthcare Policy
    • Musculoskeletal Conditions
    • Nephrologic/Hepatologic Conditions
    • Neurological Disorders
    • Oncology
    • Ophthalmology
    • Other Conditions
    • Perspective
    • Psychological Conditions
    • Respiratory Diseases
    • Trauma Induced Conditions
    • Urological/Gynecological Diseases
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Journal Policies
  • For Reviewers
  • search
  • X (formerly Twitter) (opens in a new tab)
  • Bluesky (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:32551/feed
ISSN 2327-2236
Endocrinology
Vol. 1, Issue 2, 2013August 15, 2013 EDT

Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey

Ilhan Satman, Hayley Bennett, Candeger Yilmaz, Sazi Imamoglu, Goksun Ayvaz, Abdurrahman Comlekci, Demet Ozkaya, Toros Sahin,
turkeytype 2 diabetesnph insulininsulin glarginecost effectiveness
Copyright Logoccby-4.0 • https://doi.org/10.36469/9858

Articles in Vol. 1, Issue 2, 2013

Vol. 1, Issue 2, 2013
  • A Time-motion Comparison of Itemized Treatment Costs in First and Second In Vitro Fertilization Attempts: A United Kingdom Fertility Centre Experience
    Christopher A. JonesOlivia J. CarpinelloDev KumarLouis G. KeithRenju S. RajE. Scott Sills
  • The Cost-effectiveness of Celecoxib versus Non-steroidal Anti-inflammatory Drugs plus Proton-pump Inhibitors for Treating Osteoarthritis in Algeria
    Nadir HammoumraouiSid Ahmed KherrafJoaquin Mould-QuevedoTarek A. Ismail
  • The Cost Effectiveness of Hand Held Ultrasound Scanning for Abdominal Aortic Aneurysm in Older Males with a History of Smoking
    Denver PhiriPeter J. MallowJohn A. Rizzo
  • Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey
    Ilhan SatmanHayley BennettCandeger YilmazSazi ImamogluGoksun AyvazAbdurrahman ComlekciDemet OzkayaToros Sahin
  • Incremental Healthcare Costs and Outpatient Antifungal Treatment of Patients with Aspergillosis in the United States
    Emily DurdenDonna McMorrowPaul JuneauRobert FowlerParesh ChaudhariDavid Horn
  • A Retrospective Patient Chart Review and Survey in Patients with Cryopyrin-associated Periodic Syndromes Treated with Anakinra
    Helen J. LachmannRenée J.G. ArnoldMarco GattornoIsabelle Koné-PautAlberto FerreiraJasmin Kümmerle-Deschner
  • High Costs of Dialysis Transportation in the United States: Exploring Approaches to a More Cost-effective Delivery System
    J. Mark StephensSamuel BrothertonStephan C. DunningLarry C. EmersonDavid T. GilbertsonMatthew GitlinAnn C. McClellanWilliam M. McClellanSanatan Shreay
  • Lifetime Health Care Costs of the Danish Population
    Jan SørensenRikke Søgaard
  • Assessing the Economic Burden and Health Care Utilizations of U.S. Veteran Patients with Schizophrenia
    Lin XieM. Furaha KariburyoJuan DuYuexi Wang
JHEOR
1.
Satman I, Bennett H, Yilmaz C, et al. Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey. JHEOR. 2013;1(2):108-122. doi:10.36469/9858
Save article as...▾

View more stats

Powered by Scholastica, the modern academic journal management system